Finnland - Finnisch - Fimea (Suomen lääkevirasto)

krka, d.d., novo mesto - dexketoprofen trometamol - injektio-/infuusioneste, liuos - 50 mg / 2 ml - deksketoprofeeni

Finnland - Finnisch - Fimea (Suomen lääkevirasto)

zentiva, k.s. - pemetrexed disodium - infuusioneste, liuos - 10 mg/ml - pemetreksedi

Europäische Union - Finnisch - EMA (European Medicines Agency)

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - antineoplastiset aineet - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Europäische Union - Finnisch - EMA (European Medicines Agency)

astrazeneca ab - tremelimumab - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.